Joint Formulary & PAD

Azelastine hydrochloride - Allergic conjunctivitis

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Non Formulary
Formulations :
  • Eye drops
Associated Icons :
BNF SPC
NFD1
Restrictions / Comments :

Documentation

  • No records returned.

PAD Profile

ChemicalSubstance :
Azelastine hydrochloride
Indication :
Allergic conjunctivitis
Group Name :
Keywords :
Brand Names Include :
Optilast, Aller-eze
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
0

Other Indications

Below are listed other indications that Azelastine hydrochloride is used to treat.

Other Drugs

Below are listed other drugs that are used to treat Allergic conjunctivitis.

Committee Recommendations (1)

The Surrey Heartlands Area Prescribing Committee agreed the traffic light status of this drug and indication as part of the Joint Formulary review.